FDA Inspection 919379 — Hospira, Inc.

Hospira, Inc. — FEI 3004591926

The FDA completed an inspection of Hospira, Inc. on April 13, 2015 in Lake Forest, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 13, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lake Forest, IL (United States)

Additional Details

Sponsor, Contract Research Organization